NHS

Cancer Drug Prices "Harming Patients"

Wednesday, 1 May, 2013 - 16:45

A group of 100 leading cancer specialists have spoken out about high prices for cancer drugs. Some chronic myeloid leukaemia treatments approved in the US, but not licensed in the UK range between £76,000 and £100,000 per patient per year. The cost of the drug Gilvec has in fact risen since all the original research costs were covered.

In the journal Blood the physicians say that the unsustainable expense "may be causing harm to patients" and are advocating that reasonable prices are "a necessity to save the lives of patients who cannot afford them".

NHS Whistle-blowers: 'We must protect patients"

Monday, 18 February, 2013 - 16:00

Former NHS service manager Gary Walker spoke out to the BBC claiming he was gagged by the NHS from raising concerns about patient safety. He explained that he felt pressured in to signing a "super gag" agreement because he was afraid of losing his house. It was revealed on the Today programme that this gagging order was also extended to his family.

Loz Kaye commented on the situation:

Pages